Article thumbnail

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

By Antonin LEVY, Lizza HENDRIKS, Thierry Berghmans, Corinne Faivre-Finn, Matteo Giaj-Levra, Niccolò Giaj-Levra, Baktiar Hasan, Alessia Pochesci, Nicolas Girard, Laurent Greillier, Sylvie Lantuejoul, Christopher John Edwards, Mary O‘ Brien, Martin Reck, Benjamin Besse, Silvia Novello, Anne-Marie C Dingemans and European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group


Synchronous oligometastatic disease (sOM) has been described as a distinct disease entity; however, there is no consensus on OM definition (OM-d) in non-small-cell lung cancer (NSCLC). A consensus group was formed aiming to agree on a common OM-d that could be used in future clinical trials. A European survey was circulated to generate questions and input for the consensus group

Topics: Sciences bio-médicales et agricoles, Consensus, Non-small cell lung cancer, Oligometastasis
Publisher: 'Elsevier BV'
Year: 2019
DOI identifier: 10.1016/j.ejca.2019.09.012
OAI identifier:
Provided by: DI-fusion
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles